Clinical Trial Update: Celecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating celecoxib added to surgery and radiation for advanced head and neck cancer; the study was terminated with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hypopharyngeal Cancer
• Laryngeal Cancer
• Nasal Cavity and Paranasal Sinus Carcinoma
• Oral Cavity Cancer
• Oropharyngeal Cancer

Drugs mentioned

• Celecoxib (Celecoxib)

Snippet

Sponsor: University of Utah | Conditions: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Phase 2 | Status: TERMINATED | Results posted: 2025-02-12